The European Commission (EC) has granted approval for the proposed acquisition of Swiss-based pharmaceuticals and biotechnology company Actelion by Johnson & Johnson.
Eli Lilly and Company and Incyte Corporation announced that the European Commission has granted marketing authorization for Olumiant® (baricitinib) 4 mg and 2 mg film-coated tablets in Europe for the treatment of moderate-to-severe active rheumatoid arthr
Five Prime Therapeutics, Inc. (Nasdaq:FPRX) today announced that the European Commission has granted orphan designation for cabiralizumab (FPA008) for the treatment of tenosynovial giant cell tumour.